Small Molecules
25 October 2013
FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients24 October 2013
Cornerstone Pharmaceuticals Announces Initiation of Phase II Clinical Trial of CPI-613 for the Treatment of Small Cell Lung Cancer24 October 2013
Rigel Provides Pipeline Update23 October 2013
Basilea’s antibiotic ceftobiprole obtains regulatory approval in Europe for pneumonia23 October 2013
Sucampo and Takeda Initiate Pivotal Trial of Lubiprostone Liquid Formulation in Adults With Chronic Idiopathic Constipation23 October 2013
vasopharm Reports Endorsement of Phase III Trial Design in Traumatic Brain Injury by European Medicines Agency22 October 2013
Pfizer Inc. Continues Development Program for Remoxy® (oxycodone) Extended-Release Capsules CII22 October 2013
Cubist Announces Submission of New Drug Application for Investigational Antibiotic Tedizolid for Treatment of Serious Skin Infections22 October 2013
Sucampo Announces Completion of Patient Enrollment in a Phase 3 Clinical Study of Unoprostone Isopropyl for Retinitis Pigmentosa21 October 2013
Elcelyx Therapeutics Announces Positive Results in Phase 2b Study of NewMet in Type 2 Diabete21 October 2013
MEI Pharma’s Mitochondrial Inhibitor ME-344 Shows Preliminary Evidence of Single-Agent Activity in First-in-Human Clinical Study21 October 2013
Verastem Announces Presentation of VS-6063 Clinical and Preclinical Study Results at the 2013 AACR-NCI-EORTC International Conferenc21 October 2013
Cubist Announces FDA Approval for Expanded Use of ENTEREG21 October 2013
Stellar Biotechnologies Immunotherapy Technology Demonstrates Protection Against Clostridium Difficile Infection in Preclinical Study21 October 2013
New once-daily Striverdi* (olodaterol) Respimat® gains approval in first EU countries21 October 2013
Ranbaxy receives CDSCO approval to market SynriamTM in India for treatment of malaria caused by Plasmodium vivax parasite19 October 2013
Proteostasis Therapeutics Presents Promising Preclinical Data at the 27th Annual North American Cystic Fibrosis Conference19 October 2013
Actelion receives US FDA approval of Opsumit (macitentan) for the treatment of pulmonary arterial hypertension19 October 2013
ARIAD Announces Discontinuation of the Phase 3 Epic Trial of Iclusig in Patients with Newly Diagnosed Chronic Myeloid Leukemia19 October 2013
Iroko Pharmaceuticals Receives FDA Approval for ZORVOLEXNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports